Latest News
NICE Endorses Brainomix 360 Stroke
New guidance from NICE, the globally respected health assessor, endorses the use of Brainomix 360 Stroke, acknowledging the impact that the AI-enabled software has demonstrated on stroke care, expanding patient access to life-changing treatments. Brainomix was one of only two companies granted this highly coveted endorsement.
Brainomix and Nanoflex Robotics to Collaborate on an AI-Assisted Robotic System for Remote Stroke Intervention
Brainomix Awarded Innovate UK Grant to Collaborate with Swiss-based Nanoflex Robotics
Brainomix Software Used in Post-Hoc Assessment of Acticor Biotech's ACTIMIS Study Results
The results generated by Brainomix's core lab analysis with its AI software reinforced glenzocimab's mode of action in stroke patients
Brainomix AI Technology Improves Access to Life-Changing Stroke Treatments
Sites with e-Stroke are delivering higher thrombectomy rates for stroke patients in a faster time, according to a recent report from the Oxford Academic Health Science Network
Brainomix Expands its UK Headquarters with New Facilities in Oxford
We've relocated to the landmark Seacourt Tower in Botley
Brainomix Joins CEO Roundtable on Cancer as Newest Member
The Oxford-based company is the first AI imaging company to join the organization
Brainomix Receives FDA Clearance for Its Flagship Stroke AI Imaging Software
Our stroke AI solutions are now poised to take its transformative technology to US stroke centers
Brainomix Technology Integrated into New UK Atrial Fibrillation Study
The study will assess the role of Huawei’s wearable technology to detect atrial fibrillation in post-stroke patients
Blackford and Brainomix Announce AI Partnership for Stroke Care
Strategic partnership increases access to advanced AI-assisted stroke care
Brainomix announces new partnership with Pixyl to expand its offering with multiple sclerosis solution
Brainomix to distribute Pixyl.Neuro.MS Software as a Service (SaaS) solution exclusively in the UK and Ireland, the Nordics and key Eastern Europe markets
Visionable and Brainomix announce strategic partnership to tackle “bottlenecks” in time-sensitive stroke care pathway
Benefits of combining Visionable’s virtual platform with Brainomix’s e-Stroke imaging already demonstrated at Ipswich Hospital
Brainomix Announces Collaboration with UK Government-Funded NCIMI to Evaluate AI-Powered Technology in Lung Cancer Care
Study to evaluate e-ACT for automated assessment of disease progression and treatment response for lung cancer
Brainomix and Bridge Biotherapeutics, Inc. Announce Partnership to Utilize Brainomix’ AI-Powered e-ILD Software for Automated Assessment of Idiopathic Pulmonary Fibrosis (IPF)
The partnership will focus on quantitative analysis of imaging data by Brainomix's e-ILD software within the Phase 2 Study of BBT-877 in IPF
Brainomix's AI Software to be Rolled Out Across Hungary’s Entire National Healthcare System to Improve Stroke Care
Brainomix awarded a world-first, nationwide tender for its e-Stroke platform, which will be deployed across all stroke centers in Hungary as part of the National Institute for Health Development initiative to improve stroke care.
Brainomix Expands Leadership Team with Appointment of Melissa Strange as Chief Financial Officer and Jérôme Galbrun as Chief Revenue Officer
New CFO and CRO appointed with overall resources more than doubling following last December’s £16M financing round
Brainomix Announces the Development of a Proprietary AI-Trained Predictive Biomarker for Idiopathic Pulmonary Fibrosis (IPF)
The imaging biomarker has demonstrated superior prognostic value compared with traditional measures, and may provide a more reliable measurement of the effects of novel therapies in clinical trials
Brainomix Announces New Partnership with Boehringer Ingelheim to Develop AI-Powered Radiomic Software for Automated Assessment of Solid Tumor Cancer
The collaboration will focus on the development of AI tools to improve the accuracy and standardization of tumor measurement in lung cancer trials
Brainomix Closes £16M ($21.2M) Financing Round to Expand Its Proven AI-Enabled Platform Beyond Stroke
The Series B investment will enable the Oxford-based company to expand its award-winning artificial intelligence (AI) portfolio into new indications and extend into new high-growth markets
Brainomix’s AI Stroke Software Goes Live Across Poland
Brainomix were awarded the first national tender in Europe to deploy its AI stroke software as part of the Polish Ministry of Health initiative to improve stroke care
Brainomix Announces New Partnership with Stryker Neurovascular to Expand Access to Life-Saving Stroke Treatments
The partnership will enable both companies to work towards improving care across stroke networks
Brainomix Announced as Founder Member of Open Source Imaging Consortium (OSIC)
Joins renowned global organization connecting academia, industry and philanthropy in the fight against lung disease
Brainomix Announces Appointment of New Chairperson and Expanded Board
The Oxford-based company at the forefront of medical AI imaging welcomes new Board members with pharmaceutical and imaging expertise
Brainomix Secures £7m ($9.8m) Investment to Tackle Stroke with AI
Brainomix builds on partnership with Boehringer Ingelheim for AI-assisted fast treatment of stroke victims
Brainomix Announces Partnership with Boehringer Ingelheim's Angels Initiative
Partnership will enable both companies to help improve stroke care across the region
Brainomix Completes a £1.5 Million Investment Round
Funding will enable Brainomix to further commercialize its proprietary software
Brainomix receives funding to develop clinical decision-making software for stroke patients
Brainomix Limited, a developer of automated medical imaging software for neurological
Brainomix launches revolutionary e-ASPECTS software designed to improve outcomes for stroke patients
Breakthrough technology automates analysis of CT brain scans to support doctors in
Our Partners
